Hospital-based seroepidemiological analysis of varicella antibodies in children without history of varicella disease
DOI:
https://doi.org/10.3855/jidc.20424Keywords:
varicella, seropositivity, IgG, vaccine, antibodyAbstract
Introduction: There are no published studies on the anti-varicella zoster virus (VZV) IgG antibody status of children in Qingdao. Thus, the aim of the present study was to investigate anti-VZV antibody status in hospital-based children aged 0–13 years without a history of varicella disease.
Methodology: Children aged 0–13 years in Qingdao were included in the study population. The demographic data and vaccination histories of all the subjects were obtained from the Shandong Information System for Immunization Program. Varicella disease history data was obtained from the Chinese Information System for Disease Control and Prevention. Enzyme-linked immunosorbent assay was used for detecting anti-VZV IgG in serum samples, and the seropositivity rate and geometric mean concentration (GMC) of the antibody were analyzed.
Results: A total of 983 children were included in the study. The seropositivity rate was 55.04%, and the GMC was 121.74 mIU/mL. The seropositivity rate and antibody GMC were significantly higher in females than in males (p < 0.05) and significantly higher in children aged 4–6 years than in children aged < 4 years and 7–13 years (p < 0.001). The seropositivity rate and GMC in children increased with vaccine dose (p < 0.001). In contrast to the considerable decline in antibody levels 3–5 years after one dose of varicella vaccination, antibody levels observed at least 8 years after two doses of varicella vaccination showed no considerable decline.
Conclusions: Two-dose varicella vaccination is recommended for inclusion in China’s national immunization program.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zhongyang Zhang, Zengsheng Chen, Xiaofan Li, Ping Hu, Sicheng Hao, Sitong Liu, Feng Yang

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

